Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 346

1.

Corrigendum: Identification and characterization of novel mosquito-borne (Kammavanpettai virus) and tick-borne (Wad Medani) reoviruses isolated in India.

Yadav PD, Shete AM, Nyayanit DA, Albarino CG, Jain S, Guerrero LW, Kumar S, Patil DY, Nichol ST, Mourya DT.

J Gen Virol. 2019 Sep;100(9):1340. doi: 10.1099/jgv.0.001127. No abstract available.

PMID:
31481150
2.

Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine.

Spengler JR, Welch SR, Scholte FEM, Coleman-McCray JD, Harmon JR, Nichol ST, Bergeron É, Spiropoulou CF.

Antiviral Res. 2019 Aug 1;170:104573. doi: 10.1016/j.antiviral.2019.104573. [Epub ahead of print]

PMID:
31377243
3.

Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection.

Scholte FEM, Hua BL, Spengler JR, Dzimianski JV, Coleman-McCray JD, Welch SR, McMullan LK, Nichol ST, Pegan SD, Spiropoulou CF, Bergeron É.

MBio. 2019 Jul 23;10(4). pii: e01065-19. doi: 10.1128/mBio.01065-19.

4.

Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis.

McMullan LK, Flint M, Chakrabarti A, Guerrero L, Lo MK, Porter D, Nichol ST, Spiropoulou CF, Albariño C.

Lancet Infect Dis. 2019 Sep;19(9):1023-1032. doi: 10.1016/S1473-3099(19)30291-9. Epub 2019 Jul 9.

PMID:
31300330
5.

Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon Particles.

Kainulainen MH, Spengler JR, Welch SR, Coleman-McCray JD, Harmon JR, Scholte FEM, Goldsmith CS, Nichol ST, Albariño CG, Spiropoulou CF.

J Infect Dis. 2019 Sep 13;220(8):1281-1289. doi: 10.1093/infdis/jiz284.

PMID:
31152662
6.

Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge.

Lo MK, Feldmann F, Gary JM, Jordan R, Bannister R, Cronin J, Patel NR, Klena JD, Nichol ST, Cihlar T, Zaki SR, Feldmann H, Spiropoulou CF, de Wit E.

Sci Transl Med. 2019 May 29;11(494). pii: eaau9242. doi: 10.1126/scitranslmed.aau9242.

PMID:
31142680
7.

Transmission of Nipah Virus - 14 Years of Investigations in Bangladesh.

Nikolay B, Salje H, Hossain MJ, Khan AKMD, Sazzad HMS, Rahman M, Daszak P, Ströher U, Pulliam JRC, Kilpatrick AM, Nichol ST, Klena JD, Sultana S, Afroj S, Luby SP, Cauchemez S, Gurley ES.

N Engl J Med. 2019 May 9;380(19):1804-1814. doi: 10.1056/NEJMoa1805376.

PMID:
31067370
8.

Comparative analysis of serologic cross-reactivity using convalescent sera from filovirus-experimentally infected fruit bats.

Schuh AJ, Amman BR, Sealy TS, Flietstra TD, Guito JC, Nichol ST, Towner JS.

Sci Rep. 2019 Apr 30;9(1):6707. doi: 10.1038/s41598-019-43156-z.

9.

Lassa Virus Targeting of Anterior Uvea and Endothelium of Cornea and Conjunctiva in Eye of Guinea Pig Model.

Gary JM, Welch SR, Ritter JM, Coleman-McCray J, Huynh T, Kainulainen MH, Bollweg BC, Parihar V, Nichol ST, Zaki SR, Spiropoulou CF, Spengler JR.

Emerg Infect Dis. 2019 May;25(5):865-874. doi: 10.3201/eid2505.181254.

10.

Using healthcare-seeking behaviour to estimate the number of Nipah outbreaks missed by hospital-based surveillance in Bangladesh.

Hegde ST, Salje H, Sazzad HMS, Hossain MJ, Rahman M, Daszak P, Klena JD, Nichol ST, Luby SP, Gurley ES.

Int J Epidemiol. 2019 Apr 11. pii: dyz057. doi: 10.1093/ije/dyz057. [Epub ahead of print]

PMID:
30977803
11.

Characterization of Novel Reoviruses Wad Medani Virus (Orbivirus) and Kundal Virus (Coltivirus) Collected from Hyalomma anatolicum Ticks in India during Surveillance for Crimean Congo Hemorrhagic Fever.

Yadav PD, Whitmer SLM, Sarkale P, Fei Fan Ng T, Goldsmith CS, Nyayanit DA, Esona MD, Shrivastava-Ranjan P, Lakra R, Pardeshi P, Majumdar TD, Francis A, Klena JD, Nichol ST, Ströher U, Mourya D.

J Virol. 2019 Jun 14;93(13). pii: e00106-19. doi: 10.1128/JVI.00106-19. Print 2019 Jul 1.

PMID:
30971476
12.

Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice.

Scholte FEM, Spengler JR, Welch SR, Harmon JR, Coleman-McCray JD, Freitas BT, Kainulainen MH, Pegan SD, Nichol ST, Bergeron É, Spiropoulou CF.

Emerg Microbes Infect. 2019;8(1):575-578. doi: 10.1080/22221751.2019.1601030. No abstract available.

13.

Suboptimal Handling of Piccolo Samples or Reagent Discs for Consideration in Ebola Response.

Spengler JR, Welch SR, Genzer SC, Coleman-McCray J, Harmon JR, Nichol ST, Spiropoulou CF.

Emerg Infect Dis. 2019 Jun;25(6):1238-1240. doi: 10.3201/eid2506.181928. Epub 2019 Jun 17.

14.

Marburg virus disease outbreak in Kween District Uganda, 2017: Epidemiological and laboratory findings.

Nyakarahuka L, Shoemaker TR, Balinandi S, Chemos G, Kwesiga B, Mulei S, Kyondo J, Tumusiime A, Kofman A, Masiira B, Whitmer S, Brown S, Cannon D, Chiang CF, Graziano J, Morales-Betoulle M, Patel K, Zufan S, Komakech I, Natseri N, Chepkwurui PM, Lubwama B, Okiria J, Kayiwa J, Nkonwa IH, Eyu P, Nakiire L, Okarikod EC, Cheptoyek L, Wangila BE, Wanje M, Tusiime P, Bulage L, Mwebesa HG, Ario AR, Makumbi I, Nakinsige A, Muruta A, Nanyunja M, Homsy J, Zhu BP, Nelson L, Kaleebu P, Rollin PE, Nichol ST, Klena JD, Lutwama JJ.

PLoS Negl Trop Dis. 2019 Mar 18;13(3):e0007257. doi: 10.1371/journal.pntd.0007257. eCollection 2019 Mar.

15.

Infection with New York Orthohantavirus and Associated Respiratory Failure and Multiple Cerebral Complications.

Fernando R, Capone D, Elrich S, Mantovani R, Quarles L 3rd, D'Amato A, Lowe N, Malhotra A, Khoo T, Zufan S, Morales-Betoulle M, Brown SM, Cannon D, Graziano JC, Klena JD, Whitmer S, Nichol ST, Strachan P, Camins BC, Marcos LA.

Emerg Infect Dis. 2019 Jun;25(6):1241-1243. doi: 10.3201/eid2506.181966. Epub 2019 Jun 17.

16.

Clinical, Histopathologic, and Immunohistochemical Characterization of Experimental Marburg Virus Infection in A Natural Reservoir Host, the Egyptian Rousette Bat (Rousettus aegyptiacus).

Jones MEB, Amman BR, Sealy TK, Uebelhoer LS, Schuh AJ, Flietstra T, Bird BH, Coleman-McCray JD, Zaki SR, Nichol ST, Towner JS.

Viruses. 2019 Mar 2;11(3). pii: E214. doi: 10.3390/v11030214.

17.

Discovery and Characterization of Bukakata orbivirus (Reoviridae:Orbivirus), a Novel Virus from a Ugandan Bat.

Fagre AC, Lee JS, Kityo RM, Bergren NA, Mossel EC, Nakayiki T, Nalikka B, Nyakarahuka L, Gilbert AT, Peterhans JK, Crabtree MB, Towner JS, Amman BR, Sealy TK, Schuh AJ, Nichol ST, Lutwama JJ, Miller BR, Kading RC.

Viruses. 2019 Mar 2;11(3). pii: E209. doi: 10.3390/v11030209.

18.

First Laboratory-Confirmed Outbreak of Human and Animal Rift Valley Fever Virus in Uganda in 48 Years.

Shoemaker TR, Nyakarahuka L, Balinandi S, Ojwang J, Tumusiime A, Mulei S, Kyondo J, Lubwama B, Sekamatte M, Namutebi A, Tusiime P, Monje F, Mayanja M, Ssendagire S, Dahlke M, Kyazze S, Wetaka M, Makumbi I, Borchert J, Zufan S, Patel K, Whitmer S, Brown S, Davis WG, Klena JD, Nichol ST, Rollin PE, Lutwama J.

Am J Trop Med Hyg. 2019 Mar;100(3):659-671. doi: 10.4269/ajtmh.18-0732.

19.

Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1.

McElroy AK, Shrivastava-Ranjan P, Harmon JR, Martines RB, Silva-Flannery L, Flietstra TD, Kraft CS, Mehta AK, Lyon GM, Varkey JB, Ribner BS, Nichol ST, Zaki SR, Spiropoulou CF.

Emerg Infect Dis. 2019 Feb;25(2):290-298. doi: 10.3201/eid2502.181326.

20.

A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus.

Flint M, Chatterjee P, Lin DL, McMullan LK, Shrivastava-Ranjan P, Bergeron É, Lo MK, Welch SR, Nichol ST, Tai AW, Spiropoulou CF.

Nat Commun. 2019 Jan 17;10(1):285. doi: 10.1038/s41467-018-08135-4.

21.

Adaptive immune responses in humans during Nipah virus acute and convalescent phases of infection.

Arunkumar G, Devadiga S, McElroy AK, Prabhu S, Sheik S, Abdulmajeed J, Robin S, Sushama A, Jayaram A, Nittur S, Shakir M, Kumar KGS, Radhakrishnan C, Sakeena K, Vasudevan J, Reena KJ, Sarita RL, Klena JD, Spiropoulou CF, Laserson KF, Nichol ST.

Clin Infect Dis. 2019 Jan 7. doi: 10.1093/cid/ciz010. [Epub ahead of print]

PMID:
30615097
22.

Antibody-Mediated Virus Neutralization Is Not a Universal Mechanism of Marburg, Ebola, or Sosuga Virus Clearance in Egyptian Rousette Bats.

Schuh AJ, Amman BR, Sealy TK, Kainulainen MH, Chakrabarti AK, Guerrero LW, Nichol ST, Albarino CG, Towner JS.

J Infect Dis. 2019 May 5;219(11):1716-1721. doi: 10.1093/infdis/jiy733.

23.

Complete Genome Sequences of Monongahela Hantavirus from Pennsylvania, USA.

Albariño CG, Wiggleton Guerrero L, Chakrabarti AK, Rollin PE, Nichol ST.

Microbiol Resour Announc. 2018 Sep 20;7(11). pii: e00928-18. doi: 10.1128/MRA.00928-18. eCollection 2018 Sep.

24.

Care of Ebola Survivors and Factors Associated With Clinical Sequelae-Monrovia, Liberia.

de St Maurice A, Ervin E, Orone R, Choi M, Dokubo EK, Rollin PE, Nichol ST, Williams D, Brown J, Sacra R, Fankhauser J, Knust B.

Open Forum Infect Dis. 2018 Sep 21;5(10):ofy239. doi: 10.1093/ofid/ofy239. eCollection 2018 Oct.

25.

Notes from the Field: Contact Tracing Investigation after First Case of Andes Virus in the United States - Delaware, February 2018.

Kofman A, Eggers P, Kjemtrup A, Hall R, Brown SM, Morales-Betoulle M, Graziano J, Zufan SE, Whitmer SLM, Cannon DL, Chiang CF, Choi MJ, Rollin PE, Cetron MS, Yaglom HD, Duwell M, Kuhar DT, Kretschmer M, Knust B, Klena JD, Alvarado-Ramy F, Shoemaker T, Towner JS, Nichol ST.

MMWR Morb Mortal Wkly Rep. 2018 Oct 19;67(41):1162-1163. doi: 10.15585/mmwr.mm6741a7. No abstract available.

26.

Notes from the Field: Exported Case of Sin Nombre Hantavirus Pulmonary Syndrome - Israel, 2017.

Kofman A, Rahav G, Yazzie D, Shorty H, Yaglom HD, Peterson D, Peek-Bullock M, Choi MJ, Wieder-Finesod A, Klena JD, Venkat H, Chiang CF, Knust B, Gaither M, Maurer M, Hoeschele DR, Nichol ST.

MMWR Morb Mortal Wkly Rep. 2018 Oct 12;67(40):1129. doi: 10.15585/mmwr.mm6740a5. No abstract available. Erratum in: MMWR Morb Mortal Wkly Rep. 2018 Oct 26;67(42):1197.

27.

CD4 T Cells, CD8 T Cells, and Monocytes Coordinate To Prevent Rift Valley Fever Virus Encephalitis.

Harmon JR, Spengler JR, Coleman-McCray JD, Nichol ST, Spiropoulou CF, McElroy AK.

J Virol. 2018 Nov 27;92(24). pii: e01270-18. doi: 10.1128/JVI.01270-18. Print 2018 Dec 15.

28.

Characterization of Unknown Orthobunya-Like Viruses from India.

Whitmer SLM, Yadav PD, Sarkale P, Chaubal GY, Francis A, Klena J, Nichol ST, Ströher U, Mourya DT.

Viruses. 2018 Aug 24;10(9). pii: E451. doi: 10.3390/v10090451.

29.

Transcriptional analysis of viral mRNAs reveals common transcription patterns in cells infected by five different filoviruses.

Albariño CG, Wiggleton Guerrero L, Chakrabarti AK, Nichol ST.

PLoS One. 2018 Aug 2;13(8):e0201827. doi: 10.1371/journal.pone.0201827. eCollection 2018.

30.

The S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig Model.

Welch SR, Scholte FEM, Albariño CG, Kainulainen MH, Coleman-McCray JD, Guerrero LW, Chakrabarti AK, Klena JD, Nichol ST, Spengler JR, Spiropoulou CF.

Front Cell Infect Microbiol. 2018 Jul 11;8:240. doi: 10.3389/fcimb.2018.00240. eCollection 2018.

31.

Human immune cell engraftment does not alter development of severe acute Rift Valley fever in mice.

Spengler JR, McElroy AK, Harmon JR, Coleman-McCray JD, Welch SR, Keck JG, Nichol ST, Spiropoulou CF.

PLoS One. 2018 Jul 20;13(7):e0201104. doi: 10.1371/journal.pone.0201104. eCollection 2018.

32.

Human Biomarkers of Outcome Following Rift Valley Fever Virus Infection.

McElroy AK, Harmon JR, Flietstra T, Nichol ST, Spiropoulou CF.

J Infect Dis. 2018 Oct 20;218(11):1847-1851. doi: 10.1093/infdis/jiy393.

PMID:
29955891
33.

Identification and characterization of novel mosquito-borne (Kammavanpettai virus) and tick-borne (Wad Medani) reoviruses isolated in India.

Yadav PD, Shete AM, Nyayanit DA, Albarino CG, Jain S, Guerrero LW, Kumar S, Patil DY, Nichol ST, Mourya DT.

J Gen Virol. 2018 Aug;99(8):991-1000. doi: 10.1099/jgv.0.001102. Epub 2018 Jun 25.

PMID:
29939123
34.

Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model.

Kainulainen MH, Spengler JR, Welch SR, Coleman-McCray JD, Harmon JR, Klena JD, Nichol ST, Albariño CG, Spiropoulou CF.

J Infect Dis. 2018 May 25;217(12):1957-1966. doi: 10.1093/infdis/jiy123.

35.

Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.

Smith DR, Johnston SC, Piper A, Botto M, Donnelly G, Shamblin J, Albariño CG, Hensley LE, Schmaljohn C, Nichol ST, Bird BH.

PLoS Negl Trop Dis. 2018 May 9;12(5):e0006474. doi: 10.1371/journal.pntd.0006474. eCollection 2018 May.

36.

Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations.

de St Maurice A, Harmon J, Nyakarahuka L, Balinandi S, Tumusiime A, Kyondo J, Mulei S, Namutebi A, Knust B, Shoemaker T, Nichol ST, McElroy AK, Spiropoulou CF.

PLoS Negl Trop Dis. 2018 May 4;12(5):e0006460. doi: 10.1371/journal.pntd.0006460. eCollection 2018 May.

37.

Prevalence and risk factors of Rift Valley fever in humans and animals from Kabale district in Southwestern Uganda, 2016.

Nyakarahuka L, de St Maurice A, Purpura L, Ervin E, Balinandi S, Tumusiime A, Kyondo J, Mulei S, Tusiime P, Lutwama J, Klena JD, Brown S, Knust B, Rollin PE, Nichol ST, Shoemaker TR.

PLoS Negl Trop Dis. 2018 May 3;12(5):e0006412. doi: 10.1371/journal.pntd.0006412. eCollection 2018 May.

38.

Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.

Shrivastava-Ranjan P, Flint M, Bergeron É, McElroy AK, Chatterjee P, Albariño CG, Nichol ST, Spiropoulou CF.

MBio. 2018 May 1;9(3). pii: e00660-18. doi: 10.1128/mBio.00660-18.

39.

Equine Encephalosis Virus in India, 2008.

Yadav PD, Albariño CG, Nyayanit DA, Guerrero L, Jenks MH, Sarkale P, Nichol ST, Mourya DT.

Emerg Infect Dis. 2018 May;24(5):898-901. doi: 10.3201/eid2405.171844.

40.

Susceptibility of paramyxoviruses and filoviruses to inhibition by 2'-monofluoro- and 2'-difluoro-4'-azidocytidine analogs.

Lo MK, Jordan PC, Stevens S, Tam Y, Deval J, Nichol ST, Spiropoulou CF.

Antiviral Res. 2018 May;153:101-113. doi: 10.1016/j.antiviral.2018.03.009. Epub 2018 Mar 27.

41.

Impact of enhanced viral haemorrhagic fever surveillance on outbreak detection and response in Uganda.

Shoemaker TR, Balinandi S, Tumusiime A, Nyakarahuka L, Lutwama J, Mbidde E, Kofman A, Klena JD, Ströher U, Rollin PE, Nichol ST.

Lancet Infect Dis. 2018 Apr;18(4):373-375. doi: 10.1016/S1473-3099(18)30164-6. Epub 2018 Mar 21. No abstract available.

42.

Complete Genome Sequences of a Hantavirus Isolate from New York.

McMullan LK, Albariño CG, Ksiazek TG, Nichol ST, Spiropoulou CF.

Genome Announc. 2018 Mar 22;6(12). pii: e00188-18. doi: 10.1128/genomeA.00188-18.

43.

Development of a reverse genetics system for Sosuga virus allows rapid screening of antiviral compounds.

Welch SR, Chakrabarti AK, Wiggleton Guerrero L, Jenks HM, Lo MK, Nichol ST, Spiropoulou CF, Albariño CG.

PLoS Negl Trop Dis. 2018 Mar 9;12(3):e0006326. doi: 10.1371/journal.pntd.0006326. eCollection 2018 Mar.

44.

Neutralizing antibodies against flaviviruses, Babanki virus, and Rift Valley fever virus in Ugandan bats.

Kading RC, Kityo RM, Mossel EC, Borland EM, Nakayiki T, Nalikka B, Nyakarahuka L, Ledermann JP, Panella NA, Gilbert AT, Crabtree MB, Peterhans JK, Towner JS, Amman BR, Sealy TK, Nichol ST, Powers AM, Lutwama JJ, Miller BR.

Infect Ecol Epidemiol. 2018 Feb 21;8(1):1439215. doi: 10.1080/20008686.2018.1439215. eCollection 2018.

45.

New Lineage of Lassa Virus, Togo, 2016.

Whitmer SLM, Strecker T, Cadar D, Dienes HP, Faber K, Patel K, Brown SM, Davis WG, Klena JD, Rollin PE, Schmidt-Chanasit J, Fichet-Calvet E, Noack B, Emmerich P, Rieger T, Wolff S, Fehling SK, Eickmann M, Mengel JP, Schultze T, Hain T, Ampofo W, Bonney K, Aryeequaye JND, Ribner B, Varkey JB, Mehta AK, Lyon GM 3rd, Kann G, De Leuw P, Schuettfort G, Stephan C, Wieland U, Fries JWU, Kochanek M, Kraft CS, Wolf T, Nichol ST, Becker S, Ströher U, Günther S.

Emerg Infect Dis. 2018 Mar;24(3):599-602. doi: 10.3201/eid2403.171905.

46.

Active Ebola Virus Replication and Heterogeneous Evolutionary Rates in EVD Survivors.

Whitmer SLM, Ladner JT, Wiley MR, Patel K, Dudas G, Rambaut A, Sahr F, Prieto K, Shepard SS, Carmody E, Knust B, Naidoo D, Deen G, Formenty P, Nichol ST, Palacios G, Ströher U; Ebola Virus Persistence Study Group.

Cell Rep. 2018 Jan 30;22(5):1159-1168. doi: 10.1016/j.celrep.2018.01.008.

47.

Investigation of an isolated case of human Crimean-Congo hemorrhagic fever in Central Uganda, 2015.

Balinandi S, Patel K, Ojwang J, Kyondo J, Mulei S, Tumusiime A, Lubwama B, Nyakarahuka L, Klena JD, Lutwama J, Strӧher U, Nichol ST, Shoemaker TR.

Int J Infect Dis. 2018 Mar;68:88-93. doi: 10.1016/j.ijid.2018.01.013. Epub 2018 Jan 31.

48.

Severity of Disease in Humanized Mice Infected With Ebola Virus or Reston Virus Is Associated With Magnitude of Early Viral Replication in Liver.

Spengler JR, Saturday G, Lavender KJ, Martellaro C, Keck JG, Nichol ST, Spiropoulou CF, Feldmann H, Prescott J.

J Infect Dis. 2017 Dec 27;217(1):58-63. doi: 10.1093/infdis/jix562.

49.

Genome Sequences of Crimean-Congo Hemorrhagic Fever Virus Strains Isolated in South Africa, Namibia, and Turkey.

Zivcec M, Albarino CG, Guerrero LIW, Ksiazek TG, Nichol ST, Swanepoel R, Rollin PE, Spiropoulou CF.

Genome Announc. 2017 Oct 19;5(42). pii: e01060-17. doi: 10.1128/genomeA.01060-17.

50.

Rapid Determination of Ebolavirus Infectivity in Clinical Samples Using a Novel Reporter Cell Line.

Kainulainen MH, Nichol ST, Albariño CG, Spiropoulou CF.

J Infect Dis. 2017 Dec 12;216(11):1380-1385. doi: 10.1093/infdis/jix486.

Supplemental Content

Loading ...
Support Center